1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow Deferiprone: new trials by email Literature Review of Deferiprone trials Research Report on Deferiprone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Combination Therapy Compared With Single-Drug Therapy in Patients With Cardiac Diseases Deferoxamine, Deferiprone (L1) - Cardiovascular Diseases, Heart Diseases | Phase 2 | Terminated | Carelon Research | 20 | 2005-06-01 | 2018-03-01 |
Cardiovascular Diseases (1) · Heart Diseases (1) · beta-Thalassemia (1)
Carelon Research (1)
United States (1)
Elliott P, Vichinsky, MD (1) · Ellis J. Neufeld, MD (1) · John Porter, MD (1) · Patricia J. Giardina, MD (1) · Sonja McKinlay, Ph.D. (1)
U01HL065232 (1), U01HL065238 (1), U01HL065239 (1), U01HL065244 (1), U01HL065260 (1)